Comment on "Optimal Number of Examined Lymph Node May Dependent on Age in Patients With Pancreatic Adenocarcinoma"
- PMID: 32209900
- DOI: 10.1097/SLA.0000000000003811
Comment on "Optimal Number of Examined Lymph Node May Dependent on Age in Patients With Pancreatic Adenocarcinoma"
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Response to the Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients With Pancreatic Adenocarcinoma".Ann Surg. 2021 Dec 1;274(6):e674-e675. doi: 10.1097/SLA.0000000000004449. Ann Surg. 2021. PMID: 33086330 No abstract available.
Comment on
-
Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.Ann Surg. 2021 Dec 1;274(6):e554-e563. doi: 10.1097/SLA.0000000000003558. Ann Surg. 2021. PMID: 31425290
References
-
- Huang L, Jansen L, Balavarca Y, et al. Significance of examined lymph node number in accurate staging and long-term survival in resected stage I-II pancreatic cancer-more is better? A large international population-based cohort study. Ann Surg 2019; [Epub ahead of print].
-
- Ashfaq A, Pockaj BA, Gray RJ, et al. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma. J Gastrointest Surg 2014; 18:1929–1935.
-
- Hartwig W, Gluth A, Hinz U, et al. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer. Br J Surg 2016; 103:1683–1694.
-
- Davila JA, Chiao EY, Hasche JC, et al. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer. Pancreas 2009; 38:e18–e25.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical